Related Experiment Videos
Antimicrobial peptides: a potential role in ocular therapy.
1Cooperative Research Centre For Eye Research and Technology, The University of New South Wales, Sydney, Australia. y.aliwarga@cclru.unsw.edu.au
Clinical & Experimental Ophthalmology
|July 12, 2001
Summary
Antimicrobial peptides like protamine show promise for treating eye infections. They effectively kill ocular bacteria, offering a potential solution against rising antibiotic resistance.
Area of Science:
- Ophthalmology
- Microbiology
- Biochemistry
Background:
- Bacterial pathogens are a significant cause of adverse reactions associated with contact lens wear.
- The rise of antibiotic resistance necessitates the exploration of alternative antimicrobial agents.
Purpose of the Study:
- To identify antimicrobial peptides and proteins capable of eradicating or inhibiting common ocular bacteria.
- To evaluate the efficacy of selected antimicrobials against Gram-negative and Gram-positive ocular bacteria under different nutrient conditions.
Main Methods:
- Screening of antimicrobial peptides and proteins against ocular bacterial isolates.
- Assessment of bacterial viability after exposure to antimicrobials in low (phosphate-buffered saline) and high (tryptone soya broth) nutrient environments.
- Time-course analysis of bacterial response up to 48 hours.
Main Results:
- Protamine demonstrated broad-spectrum efficacy against all tested bacterial strains in low-nutrient conditions.
- Melittin was effective against most strains, with partial activity against Serratia and a Pseudomonas isolate.
- In high-nutrient conditions, melittin was effective against Staphylococcus aureus; protamine and its combination with melittin showed significant eradication in low-nutrient settings.
Conclusions:
- Protamine and melittin, particularly in combination, show potential as therapeutic agents for ocular infections.
- These antimicrobial peptides offer a promising alternative in the face of increasing antibiotic resistance in ocular pathogens.